A quiet virus today can become a devastating diagnosis decades from now. We dig into the uncomfortable math behind hepatitis B: why a universal birth dose prevents chronic infection and, by extension, a significant share of future liver cancer. The science is clear—infants who contract Hep B are far more likely to become chronically infected, and transmission often happens in ordinary settings through trivial blood contact. Waiting to vaccinate until school age sounds reasonable, but it misses the window when protection is most powerful and risk is highest.
From there, we turn to measles and the fragile line between “eliminated” and “spreading.” Elimination never meant measles disappeared; it meant high vaccination coverage kept chains short. With coverage slipping below the herd immunity threshold, outbreaks have grown, hospitalizations are up, and preventable deaths are back. We unpack the data behind the surge, why most cases are among the unvaccinated, and how even small drops in uptake reshape community risk. We also examine proposed schedule changes—MMR versus MMRV, timing debates, and febrile seizure risks—and explain why convenience and adherence often matter more than theoretical tweaks.
Throughout, we focus on first principles: protect infants early, keep schedules stable unless strong evidence demands change, and remember that some children depend entirely on our collective immunity. If you care about practical, evidence-based public health—and want clear answers on Hep B, MMR, and herd immunity—this conversation brings the data and the context you need. If it resonates, share it with a friend, subscribe, and leave a review so more people can find it. Your voice helps keep good science in the spotlight.
Thanks for listening! Follow the links below for more!
https://www.instagram.com/fitscapades
https://patreon.com/fitscapades
https://youtube.com/@fitscapades?si=hzhOJ8vjmjz5dAJy
TikTok @fitscapades1
twitter/ X fitscapades